Two complementary genome-wide association studies provide new insights into how host genetics influence the human gut microbiome.

The JAK inhibitor deuruxolitinib has been approved by the MHRA as a treatment option for adults with severe alopecia areata.

The type of valved holding chamber used with inhaled salbutamol can significantly influence clinical outcomes in acute ...

Using CDK4/6 inhibitors as first-line therapy in advanced breast cancer does not improve overall survival compared with ...

Early prophylactic hydrocortisone for extremely preterm infants may increase BPD-free survival without raising rates of complications.

People living with vitiligo experience substantial levels of mood- and stress-related mental health disorders, according to a cohort study.

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

Dr Jitesh Neupane discusses his hematoids model and opportunities to study childhood blood disorders and future stem cell therapies.

Dupilumab reduces itch severity and overall disease activity in patients with refractory chronic spontaneous urticaria (CSU), according to the results of a recent trial supporting earlier findings ...

Psoriasis symptom and quality of life improvements occur rapidly with bimekizumab and remain durable for up to three years, study shows.

Clinical measures and blood biomarkers collected during pregnancy could offer early insight into a woman’s long-term cardiovascular health.

Dr Ari Manuel joins the Clinical Excellence in Respiratory Care speaker line-up to discuss complex ventilatory failure and OSA.